Abstract
Malignancy is the second most common disease worldwide after heart disease. Cancer of any subsite is generally treated through one or more modalities of surgery, chemotherapy, and radiotherapy. Surgery and radiotherapy are local forms of treatments, but chemotherapy is systemic. The specialization in the field of systemic therapy is called medical oncology. The concept of medical oncology has come into the picture a couple of decades back. Chemotherapy, hormonal therapy, and targeted therapy have been established for the treatment of cancer. Immunotherapy and gene therapy are still in the investigational phase. Many new molecules are getting approval from the USFDA every year and changing the treatment protocol continuously.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alfarouk KO, Stock CM, Taylor S, Walsh M, Muddathir AK, Verduzco D, Bashir AH, Mohammed OY, Elhassan GO, Harguindey S, Reshkin SJ (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int 15(1):1–13
Bisht M, Bist SS, Dhasmana DC (2010) Biological response modifiers: current use and future prospects in cancer therapy. Indian J Cancer 47(4):443
Chabner BA, Roberts TG (2005) Chemotherapy and the war on cancer. Nat Rev Cancer 5(1):65–72
Chu E, Sartorelli AC (2004) Cancer chemotherapy. Basic Clin Pharmacol 9:898–930
DeVita VT, Chu E (2008) A history of cancer chemotherapy. Cancer Res 68(21):8643–8653
Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63(11–12):1727–1733
Gonzalez H, Hagerling C, Werb Z (2018) Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev 32(19–20):1267–1284
Govindan R, DeVita VT (eds) (2009) DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology review. Lippincott Williams & Wilkins
Hall EJ, Giaccia AJ (2006) Radiobiology for the radiologist (vol. 6)
Hartwell LH, Hopfield JJ, Leibler S, Murray AW (1999) From molecular to modular cell biology. Nature 402(6761):C47–C52
Jain KK (2002) Personalized medicine. Curr Opin Mol Ther 4(6):548–558
Mcleod DG (2003) Hormonal therapy: historical perspective to future directions. Urology 61(2):3–7. (Mcleod, 2003)
Mitchison DA (1979) Basic mechanisms of chemotherapy. Chest 76(6):771–780
Nagai H, Kim YH (2017) Cancer prevention from the perspective of global cancer burden patterns. J Thorac Dis 9(3):448
Sedgwick P (2011) Phases of clinical trials. BMJ 343
Tannock IF, Hill RP, Bristow RG, Harrington L (eds) (1987) The basic science of oncology. Pergamon Press, New York, p 398
Tripathi KD (1994) Essentials of medical pharmacology. Indian J Pharmacol 26(2):166
Wirth T, Ylä-Herttuala S (2014) Gene therapy used in cancer treatment. Biomedicine 2(2):149–162. https://doi.org/10.3390/biomedicines2020149
Wu HC, Chang DK, Huang CT (2006) Targeted therapy for cancer. J Cancer Mol 2(2):57–66
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Saha, M. (2022). Medical Oncology in Cancer Treatment. In: Basu, S.K., Panda, C.K., Goswami, S. (eds) Cancer Diagnostics and Therapeutics . Springer, Singapore. https://doi.org/10.1007/978-981-16-4752-9_12
Download citation
DOI: https://doi.org/10.1007/978-981-16-4752-9_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-4751-2
Online ISBN: 978-981-16-4752-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)